04.04.2017 Views

Graduate

IPU-Review-APRIL-2017

IPU-Review-APRIL-2017

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PROFESSIONAL<br />

POLITICS Stephen O’Byrnes<br />

Minister thanks pharmacists<br />

regarding over-70s<br />

prescription levy cut<br />

The Minister for Health expressed thanks to pharmacies and<br />

the HSE recently for “the swift implementation” by them of<br />

the reduction in prescription charges for persons aged 70<br />

and over, which came into effect on 1 March last.<br />

Simon Harris<br />

Fine Gael<br />

Gino Kenny<br />

People Before Profit Alliance<br />

Michael Healy-Rae<br />

Independent<br />

Tommy Broughan<br />

Independent<br />

The Minister for Health,<br />

Deputy Simon Harris (Fine<br />

Gael, Wicklow) was speaking<br />

during the Dáil debate on<br />

the Health Bill to give effect<br />

to this measure.<br />

Under a commitment<br />

made in the Programme<br />

for Government last year,<br />

it reduces the prescription<br />

charge for medical card<br />

holders aged 70 years<br />

and older, and for their<br />

dependants, to €2 per<br />

prescription item, with a<br />

monthly cap of €20 for an<br />

individual or family.<br />

Minister Harris said this<br />

would cost €12 million in a full<br />

year, and would benefit nearly<br />

390,000 people. It was expected<br />

to save this group of patients<br />

€10 million in 2017. He had<br />

decided, following consultation<br />

with the Attorney General, to<br />

introduce the reduced charges<br />

on an administrative basis<br />

by the HSE from 1 March,<br />

pending the passage of the<br />

enabling legislation.<br />

Pointing out that people<br />

aged 70 years and over<br />

had higher medication<br />

requirements than the<br />

general population, he said<br />

that, while the over 70s were<br />

just under 20% of the medical<br />

card population, nearly half<br />

of the drugs dispensed under<br />

the GMS scheme were for over<br />

70s. The average number of<br />

items dispensed per person<br />

over 70 years was seven,<br />

compared to two items per<br />

person under 70.<br />

Pharmacists and doctors to be consulted<br />

on cannabis access programme<br />

Pending the establishment of an access programme for<br />

cannabis-based treatments in Ireland, as set out recently<br />

by the Health Products Regulatory Authority’s report<br />

Cannabis for Medical Use – A Scientific Review, the Minister<br />

for Health may provide a licence for access to cannabis<br />

for medical purposes in individual cases.<br />

The Minister was replying to a number of questions<br />

in the Dáil recently on the issue. He said that the<br />

granting of such a licence must, however, be based<br />

on an appropriate application being submitted to the<br />

Department of Health by a medical consultant who is<br />

responsible for the management of the patient and who<br />

makes the clinical decision to prescribe the treatment<br />

and monitor its effects over time.<br />

Questions were posed by Deputies Gino Kenny (People<br />

Before Profit Alliance, Dublin Mid-West), Michael Healy-Rae<br />

(Independent, Kerry) and Tommy Broughan (Independent,<br />

Dublin Bay North).<br />

It was crucial, Minister Harris added, “that the granting<br />

of any such licence takes due care and consideration of the<br />

potential unintended consequences associated with the<br />

prescription of cannabis for medical purposes, and that<br />

its use is endorsed by a consultant who is familiar with<br />

and responsible for the care of the individual for whom<br />

the licence application is being made... The professional<br />

role of doctors and pharmacists is integral to the safe<br />

and effective use of all drugs which are prescribed. In<br />

establishing an access programme for medical cannabis,<br />

it is therefore critical that the expert views of these<br />

professionals, through their professional bodies, are<br />

considered. Efforts are under way to ensure that, prior to<br />

its establishment, the planned access programme reflects<br />

this expert input in order to assure clarity of the roles and<br />

responsibilities of doctors and pharmacists in prescribing<br />

and dispensing cannabis for medical purposes in the<br />

interests of safe and effective practice.” Consequently,<br />

officials from the Department of Health and the HPRA<br />

would consult with these stakeholders on how the access<br />

programme would operate.<br />

62<br />

IPUREVIEW APRIL 2017

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!